Steps taken towards competitive pharma market in Serbia?
In the beginning of January, the Commission for Protection of Competition (CPC) announced the launch of a sectoral analysis aimed at evaluating the state and conditions of competition within Serbia’s pharmaceutical market. The focus of the investigation will be on medicines for human use, specifically those on the list of drugs prescribed and dispensed through […]